1. Home
  2. MEC vs ALT Comparison

MEC vs ALT Comparison

Compare MEC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEC
  • ALT
  • Stock Information
  • Founded
  • MEC 1945
  • ALT 1997
  • Country
  • MEC United States
  • ALT United States
  • Employees
  • MEC N/A
  • ALT N/A
  • Industry
  • MEC Industrial Specialties
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEC Industrials
  • ALT Health Care
  • Exchange
  • MEC Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MEC 329.4M
  • ALT 292.0M
  • IPO Year
  • MEC 2019
  • ALT N/A
  • Fundamental
  • Price
  • MEC $14.60
  • ALT $3.83
  • Analyst Decision
  • MEC Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • MEC 3
  • ALT 6
  • Target Price
  • MEC $21.33
  • ALT $17.40
  • AVG Volume (30 Days)
  • MEC 161.8K
  • ALT 3.0M
  • Earning Date
  • MEC 08-05-2025
  • ALT 08-12-2025
  • Dividend Yield
  • MEC N/A
  • ALT N/A
  • EPS Growth
  • MEC 64.18
  • ALT N/A
  • EPS
  • MEC 0.86
  • ALT N/A
  • Revenue
  • MEC $524,606,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MEC N/A
  • ALT N/A
  • Revenue Next Year
  • MEC $17.38
  • ALT $761,880.20
  • P/E Ratio
  • MEC $17.07
  • ALT N/A
  • Revenue Growth
  • MEC N/A
  • ALT N/A
  • 52 Week Low
  • MEC $11.72
  • ALT $2.90
  • 52 Week High
  • MEC $23.02
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MEC 46.47
  • ALT 51.79
  • Support Level
  • MEC $14.22
  • ALT $3.35
  • Resistance Level
  • MEC $14.80
  • ALT $3.66
  • Average True Range (ATR)
  • MEC 0.50
  • ALT 0.19
  • MACD
  • MEC 0.07
  • ALT 0.07
  • Stochastic Oscillator
  • MEC 57.65
  • ALT 86.18

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: